Cite
HARVARD Citation
Kita, T. et al. (2022). Adrenomedullin for biologic‐resistant Crohn's disease: A randomized, double‐blind, placebo‐controlled phase 2a clinical trial. Journal of gastroenterology and hepatology. 37 (11), pp. 2051-2059. [Online].